 | • レポートコード：QAF27823 • 出版社/出版日：QYResearch / 2021年4月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のパクリタキセル注射市場について種類別（薬物強度、原料パクリタキセルAPIソース）、用途別（卵巣がん、乳がん、子宮頸がん、膵臓がん、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・パクリタキセル注射市場の概要 ・世界の主要地域別パクリタキセル注射市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のパクリタキセル注射市場規模2016-2021：種類別（薬物強度、原料パクリタキセルAPIソース） ・世界のパクリタキセル注射市場予測2012-2027：種類別（薬物強度、原料パクリタキセルAPIソース） ・世界のパクリタキセル注射市場規模2016-2021：用途別（卵巣がん、乳がん、子宮頸がん、膵臓がん、その他） ・世界のパクリタキセル注射市場予測2012-2027：用途別（卵巣がん、乳がん、子宮頸がん、膵臓がん、その他） ・パクリタキセル注射のアメリカ市場規模と予測2016-2021 ・パクリタキセル注射のヨーロッパ市場規模と予測2016-2021 ・パクリタキセル注射の中国市場規模と予測2016-2021 ・パクリタキセル注射の日本市場規模と予測2016-2021 ・パクリタキセル注射の東南アジア市場規模と予測2016-2021 ・パクリタキセル注射のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Bristol-Myers Squibb、Celgene Corporation、Hospira、Biological E.、Taj Accura、Khandelwal Laboratories、Luye Pharma、Beijing Youcare、Beijing Union、Haiyao、Chuntch） ・パクリタキセル注射の製造コスト分析 ・販売チャネル、流通業者、顧客 ・パクリタキセル注射の市場動向・機会・課題 ・調査の結論 |
Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi’s sarcoma, it may be given once every 2 or 3 weeks.
In recent years, the growing population and increasing disease incidence of ovarian cancer, breast cancer and other cancers drive the global paclitaxel injection industry developing.
In the past five years from 2010-2014, global paclitaxel injection industry developed fast with a larger than 15% annual production growth rate. In China, due to the late start, the production growth rate is 12%~17%, which is a little lower than global average.
In the next few years, with the growing attention on women cancers from the whole society and much larger investment on R&D of paclitaxel injection, this industry will continue developing at a high speed. What’s more, because of the high gross profit of producing and selling paclitaxel injection, more and more investors will enter into this industry.
At present, the production of paclitaxel injection mainly concentrated in US, China and EU, the three regions produced about 77.30% of the global total products. Of those, US are the largest production region with a 42.69% of global production market share.
In the future, with the expanded capacity of paclitaxel injection, the manufacturers will face the high risk of price and gross margin decline.
Market Analysis and Insights: Global Paclitaxel Injection Market
The global Paclitaxel Injection market was valued at US$ 3384.3 in 2020 and will reach US$ 6364.3 million by the end of 2027, growing at a CAGR of 11.1% during 2022-2027.
Global Paclitaxel Injection Scope and Market Size
The global Paclitaxel Injection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Paclitaxel Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Drug Strength
Raw Meterial Paclitaxel API Source
Segment by Application
Ovarian Cancer
Breast Cancer
Cervical Cancer
Pancreatic Cancer
Other
The Paclitaxel Injection market is analysed and market size information is provided by regions (countries). Segment by Application, the Paclitaxel Injection market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch
1 Paclitaxel Injection Market Overview
1.1 Paclitaxel Injection Product Scope
1.2 Paclitaxel Injection Segment by Type
1.2.1 Global Paclitaxel Injection Sales by Type (2016 & 2021 & 2027)
1.2.2 Drug Strength
1.2.3 Raw Meterial Paclitaxel API Source
1.3 Paclitaxel Injection Segment by Application
1.3.1 Global Paclitaxel Injection Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 Cervical Cancer
1.3.5 Pancreatic Cancer
1.3.6 Other
1.4 Paclitaxel Injection Market Estimates and Forecasts (2016-2027)
1.4.1 Global Paclitaxel Injection Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Paclitaxel Injection Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Paclitaxel Injection Price Trends (2016-2027)
2 Paclitaxel Injection Estimates and Forecasts by Region
2.1 Global Paclitaxel Injection Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Paclitaxel Injection Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Paclitaxel Injection Sales Market Share by Region (2016-2021)
2.2.2 Global Paclitaxel Injection Revenue Market Share by Region (2016-2021)
2.3 Global Paclitaxel Injection Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Paclitaxel Injection Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Paclitaxel Injection Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Paclitaxel Injection Estimates and Projections (2016-2027)
2.4.2 Europe Paclitaxel Injection Estimates and Projections (2016-2027)
2.4.3 China Paclitaxel Injection Estimates and Projections (2016-2027)
2.4.4 Japan Paclitaxel Injection Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Paclitaxel Injection Estimates and Projections (2016-2027)
2.4.6 India Paclitaxel Injection Estimates and Projections (2016-2027)
3 Global Paclitaxel Injection Competition Landscape by Players
3.1 Global Top Paclitaxel Injection Players by Sales (2016-2021)
3.2 Global Top Paclitaxel Injection Players by Revenue (2016-2021)
3.3 Global Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Paclitaxel Injection as of 2020)
3.4 Global Paclitaxel Injection Average Price by Company (2016-2021)
3.5 Manufacturers Paclitaxel Injection Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Paclitaxel Injection Market Size by Type
4.1 Global Paclitaxel Injection Historic Market Review by Type (2016-2021)
4.1.1 Global Paclitaxel Injection Sales Market Share by Type (2016-2021)
4.1.2 Global Paclitaxel Injection Revenue Market Share by Type (2016-2021)
4.1.3 Global Paclitaxel Injection Price by Type (2016-2021)
4.2 Global Paclitaxel Injection Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Paclitaxel Injection Sales Forecast by Type (2022-2027)
4.2.2 Global Paclitaxel Injection Revenue Forecast by Type (2022-2027)
4.2.3 Global Paclitaxel Injection Price Forecast by Type (2022-2027)
5 Global Paclitaxel Injection Market Size by Application
5.1 Global Paclitaxel Injection Historic Market Review by Application (2016-2021)
5.1.1 Global Paclitaxel Injection Sales Market Share by Application (2016-2021)
5.1.2 Global Paclitaxel Injection Revenue Market Share by Application (2016-2021)
5.1.3 Global Paclitaxel Injection Price by Application (2016-2021)
5.2 Global Paclitaxel Injection Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Paclitaxel Injection Sales Forecast by Application (2022-2027)
5.2.2 Global Paclitaxel Injection Revenue Forecast by Application (2022-2027)
5.2.3 Global Paclitaxel Injection Price Forecast by Application (2022-2027)
6 North America Paclitaxel Injection Market Facts & Figures
6.1 North America Paclitaxel Injection Sales by Company
6.1.1 North America Paclitaxel Injection Sales by Company (2016-2021)
6.1.2 North America Paclitaxel Injection Revenue by Company (2016-2021)
6.2 North America Paclitaxel Injection Sales Breakdown by Type
6.2.1 North America Paclitaxel Injection Sales Breakdown by Type (2016-2021)
6.2.2 North America Paclitaxel Injection Sales Breakdown by Type (2022-2027)
6.3 North America Paclitaxel Injection Sales Breakdown by Application
6.3.1 North America Paclitaxel Injection Sales Breakdown by Application (2016-2021)
6.3.2 North America Paclitaxel Injection Sales Breakdown by Application (2022-2027)
7 Europe Paclitaxel Injection Market Facts & Figures
7.1 Europe Paclitaxel Injection Sales by Company
7.1.1 Europe Paclitaxel Injection Sales by Company (2016-2021)
7.1.2 Europe Paclitaxel Injection Revenue by Company (2016-2021)
7.2 Europe Paclitaxel Injection Sales Breakdown by Type
7.2.1 Europe Paclitaxel Injection Sales Breakdown by Type (2016-2021)
7.2.2 Europe Paclitaxel Injection Sales Breakdown by Type (2022-2027)
7.3 Europe Paclitaxel Injection Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Paclitaxel Injection Market Facts & Figures
8.1 China Paclitaxel Injection Sales by Company
8.1.1 China Paclitaxel Injection Sales by Company (2016-2021)
8.1.2 China Paclitaxel Injection Revenue by Company (2016-2021)
8.2 China Paclitaxel Injection Sales Breakdown by Type
8.2.1 China Paclitaxel Injection Sales Breakdown by Type (2016-2021)
8.2.2 China Paclitaxel Injection Sales Breakdown by Type (2022-2027)
8.3 China Paclitaxel Injection Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Paclitaxel Injection Market Facts & Figures
9.1 Japan Paclitaxel Injection Sales by Company
9.1.1 Japan Paclitaxel Injection Sales by Company (2016-2021)
9.1.2 Japan Paclitaxel Injection Revenue by Company (2016-2021)
9.2 Japan Paclitaxel Injection Sales Breakdown by Type
9.2.1 Japan Paclitaxel Injection Sales Breakdown by Type (2016-2021)
9.2.2 Japan Paclitaxel Injection Sales Breakdown by Type (2022-2027)
9.3 Japan Paclitaxel Injection Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Paclitaxel Injection Market Facts & Figures
10.1 Southeast Asia Paclitaxel Injection Sales by Company
10.1.1 Southeast Asia Paclitaxel Injection Sales by Company (2016-2021)
10.1.2 Southeast Asia Paclitaxel Injection Revenue by Company (2016-2021)
10.2 Southeast Asia Paclitaxel Injection Sales Breakdown by Type
10.2.1 Southeast Asia Paclitaxel Injection Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Paclitaxel Injection Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Paclitaxel Injection Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Paclitaxel Injection Market Facts & Figures
11.1 India Paclitaxel Injection Sales by Company
11.1.1 India Paclitaxel Injection Sales by Company (2016-2021)
11.1.2 India Paclitaxel Injection Revenue by Company (2016-2021)
11.2 India Paclitaxel Injection Sales Breakdown by Type
11.2.1 India Paclitaxel Injection Sales Breakdown by Type (2016-2021)
11.2.2 India Paclitaxel Injection Sales Breakdown by Type (2022-2027)
11.3 India Paclitaxel Injection Sales Breakdown by Application
11.3.1 India Paclitaxel Injection Sales Breakdown by Application (2016-2021)
11.3.2 India Paclitaxel Injection Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Paclitaxel Injection Business
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Corporation Information
12.1.2 Bristol-Myers Squibb Business Overview
12.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bristol-Myers Squibb Paclitaxel Injection Products Offered
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Celgene Corporation
12.2.1 Celgene Corporation Corporation Information
12.2.2 Celgene Corporation Business Overview
12.2.3 Celgene Corporation Paclitaxel Injection Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Celgene Corporation Paclitaxel Injection Products Offered
12.2.5 Celgene Corporation Recent Development
12.3 Hospira
12.3.1 Hospira Corporation Information
12.3.2 Hospira Business Overview
12.3.3 Hospira Paclitaxel Injection Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Hospira Paclitaxel Injection Products Offered
12.3.5 Hospira Recent Development
12.4 Biological E.
12.4.1 Biological E. Corporation Information
12.4.2 Biological E. Business Overview
12.4.3 Biological E. Paclitaxel Injection Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Biological E. Paclitaxel Injection Products Offered
12.4.5 Biological E. Recent Development
12.5 Taj Accura
12.5.1 Taj Accura Corporation Information
12.5.2 Taj Accura Business Overview
12.5.3 Taj Accura Paclitaxel Injection Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Taj Accura Paclitaxel Injection Products Offered
12.5.5 Taj Accura Recent Development
12.6 Khandelwal Laboratories
12.6.1 Khandelwal Laboratories Corporation Information
12.6.2 Khandelwal Laboratories Business Overview
12.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Khandelwal Laboratories Paclitaxel Injection Products Offered
12.6.5 Khandelwal Laboratories Recent Development
12.7 Luye Pharma
12.7.1 Luye Pharma Corporation Information
12.7.2 Luye Pharma Business Overview
12.7.3 Luye Pharma Paclitaxel Injection Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Luye Pharma Paclitaxel Injection Products Offered
12.7.5 Luye Pharma Recent Development
12.8 Beijing Youcare
12.8.1 Beijing Youcare Corporation Information
12.8.2 Beijing Youcare Business Overview
12.8.3 Beijing Youcare Paclitaxel Injection Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Beijing Youcare Paclitaxel Injection Products Offered
12.8.5 Beijing Youcare Recent Development
12.9 Beijing Union
12.9.1 Beijing Union Corporation Information
12.9.2 Beijing Union Business Overview
12.9.3 Beijing Union Paclitaxel Injection Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Beijing Union Paclitaxel Injection Products Offered
12.9.5 Beijing Union Recent Development
12.10 Haiyao
12.10.1 Haiyao Corporation Information
12.10.2 Haiyao Business Overview
12.10.3 Haiyao Paclitaxel Injection Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Haiyao Paclitaxel Injection Products Offered
12.10.5 Haiyao Recent Development
12.11 Chuntch
12.11.1 Chuntch Corporation Information
12.11.2 Chuntch Business Overview
12.11.3 Chuntch Paclitaxel Injection Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Chuntch Paclitaxel Injection Products Offered
12.11.5 Chuntch Recent Development
13 Paclitaxel Injection Manufacturing Cost Analysis
13.1 Paclitaxel Injection Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Paclitaxel Injection
13.4 Paclitaxel Injection Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Paclitaxel Injection Distributors List
14.3 Paclitaxel Injection Customers
15 Market Dynamics
15.1 Paclitaxel Injection Market Trends
15.2 Paclitaxel Injection Drivers
15.3 Paclitaxel Injection Market Challenges
15.4 Paclitaxel Injection Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Paclitaxel Injection Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Paclitaxel Injection Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Paclitaxel Injection Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Paclitaxel Injection Sales (K Units) by Region (2016-2021)
Table 5. Global Paclitaxel Injection Sales Market Share by Region (2016-2021)
Table 6. Global Paclitaxel Injection Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Paclitaxel Injection Revenue Share by Region (2016-2021)
Table 8. Global Paclitaxel Injection Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Paclitaxel Injection Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Paclitaxel Injection Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Paclitaxel Injection Revenue Share Forecast by Region (2022-2027)
Table 12. Global Paclitaxel Injection Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Paclitaxel Injection Sales Share by Company (2016-2021)
Table 14. Global Paclitaxel Injection Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Paclitaxel Injection Revenue Share by Company (2016-2021)
Table 16. Global Paclitaxel Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paclitaxel Injection as of 2020)
Table 17. Global Paclitaxel Injection Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Paclitaxel Injection Manufacturing Sites and Area Served
Table 19. Manufacturers Paclitaxel Injection Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Paclitaxel Injection Sales (K Units) by Type (2016-2021)
Table 22. Global Paclitaxel Injection Sales Share by Type (2016-2021)
Table 23. Global Paclitaxel Injection Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Paclitaxel Injection Price (USD/Unit) by Type (2016-2021)
Table 25. Global Paclitaxel Injection Sales Share by Type (2022-2027)
Table 26. Global Paclitaxel Injection Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Paclitaxel Injection Revenue Share by Type (2022-2027)
Table 28. Global Paclitaxel Injection Price (USD/Unit) by Type (2022-2027)
Table 29. Global Paclitaxel Injection Sales (K Units) by Application (2016-2021)
Table 30. Global Paclitaxel Injection Sales Share by Application (2016-2021)
Table 31. Global Paclitaxel Injection Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Paclitaxel Injection Price (USD/Unit) by Application (2016-2021)
Table 33. Global Paclitaxel Injection Sales (K Units) by Application (2022-2027)
Table 34. Global Paclitaxel Injection Sales Share by Application (2022-2027)
Table 35. Global Paclitaxel Injection Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Paclitaxel Injection Revenue Share by Application (2022-2027)
Table 37. Global Paclitaxel Injection Price (USD/Unit) by Application (2022-2027)
Table 38. North America Paclitaxel Injection Sales (K Units) by Company (2016-2021)
Table 39. North America Paclitaxel Injection Sales Market Share by Company (2016-2021)
Table 40. North America Paclitaxel Injection Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Paclitaxel Injection Revenue Market Share by Company (2016-2021)
Table 42. North America Paclitaxel Injection Sales by Type (2016-2021) & (K Units)
Table 43. North America Paclitaxel Injection Sales Market Share by Type (2016-2021)
Table 44. North America Paclitaxel Injection Sales by Type (2022-2027) & (K Units)
Table 45. North America Paclitaxel Injection Sales Market Share by Type (2022-2027)
Table 46. North America Paclitaxel Injection Sales by Application (2016-2021) & (K Units)
Table 47. North America Paclitaxel Injection Sales Market Share by Application (2016-2021)
Table 48. North America Paclitaxel Injection Sales by Application (2022-2027) & (K Units)
Table 49. North America Paclitaxel Injection Sales Market Share by Application (2022-2027)
Table 50. Europe Paclitaxel Injection Sales (K Units) by Company (2016-2021)
Table 51. Europe Paclitaxel Injection Sales Market Share by Company (2016-2021)
Table 52. Europe Paclitaxel Injection Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Paclitaxel Injection Revenue Market Share by Company (2016-2021)
Table 54. Europe Paclitaxel Injection Sales by Type (2016-2021) & (K Units)
Table 55. Europe Paclitaxel Injection Sales Market Share by Type (2016-2021)
Table 56. Europe Paclitaxel Injection Sales by Type (2022-2027) & (K Units)
Table 57. Europe Paclitaxel Injection Sales Market Share by Type (2022-2027)
Table 58. Europe Paclitaxel Injection Sales by Application (2016-2021) & (K Units)
Table 59. Europe Paclitaxel Injection Sales Market Share by Application (2016-2021)
Table 60. Europe Paclitaxel Injection Sales by Application (2022-2027) & (K Units)
Table 61. Europe Paclitaxel Injection Sales Market Share by Application (2022-2027)
Table 62. China Paclitaxel Injection Sales (K Units) by Company (2016-2021)
Table 63. China Paclitaxel Injection Sales Market Share by Company (2016-2021)
Table 64. China Paclitaxel Injection Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Paclitaxel Injection Revenue Market Share by Company (2016-2021)
Table 66. China Paclitaxel Injection Sales by Type (2016-2021) & (K Units)
Table 67. China Paclitaxel Injection Sales Market Share by Type (2016-2021)
Table 68. China Paclitaxel Injection Sales by Type (2022-2027) & (K Units)
Table 69. China Paclitaxel Injection Sales Market Share by Type (2022-2027)
Table 70. China Paclitaxel Injection Sales by Application (2016-2021) & (K Units)
Table 71. China Paclitaxel Injection Sales Market Share by Application (2016-2021)
Table 72. China Paclitaxel Injection Sales by Application (2022-2027) & (K Units)
Table 73. China Paclitaxel Injection Sales Market Share by Application (2022-2027)
Table 74. Japan Paclitaxel Injection Sales (K Units) by Company (2016-2021)
Table 75. Japan Paclitaxel Injection Sales Market Share by Company (2016-2021)
Table 76. Japan Paclitaxel Injection Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Paclitaxel Injection Revenue Market Share by Company (2016-2021)
Table 78. Japan Paclitaxel Injection Sales by Type (2016-2021) & (K Units)
Table 79. Japan Paclitaxel Injection Sales Market Share by Type (2016-2021)
Table 80. Japan Paclitaxel Injection Sales by Type (2022-2027) & (K Units)
Table 81. Japan Paclitaxel Injection Sales Market Share by Type (2022-2027)
Table 82. Japan Paclitaxel Injection Sales by Application (2016-2021) & (K Units)
Table 83. Japan Paclitaxel Injection Sales Market Share by Application (2016-2021)
Table 84. Japan Paclitaxel Injection Sales by Application (2022-2027) & (K Units)
Table 85. Japan Paclitaxel Injection Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Paclitaxel Injection Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Paclitaxel Injection Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Paclitaxel Injection Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Paclitaxel Injection Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Paclitaxel Injection Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Paclitaxel Injection Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Paclitaxel Injection Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Paclitaxel Injection Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Paclitaxel Injection Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Paclitaxel Injection Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Paclitaxel Injection Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Paclitaxel Injection Sales Market Share by Application (2022-2027)
Table 98. India Paclitaxel Injection Sales (K Units) by Company (2016-2021)
Table 99. India Paclitaxel Injection Sales Market Share by Company (2016-2021)
Table 100. India Paclitaxel Injection Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Paclitaxel Injection Revenue Market Share by Company (2016-2021)
Table 102. India Paclitaxel Injection Sales by Type (2016-2021) & (K Units)
Table 103. India Paclitaxel Injection Sales Market Share by Type (2016-2021)
Table 104. India Paclitaxel Injection Sales by Type (2022-2027) & (K Units)
Table 105. India Paclitaxel Injection Sales Market Share by Type (2022-2027)
Table 106. India Paclitaxel Injection Sales by Application (2016-2021) & (K Units)
Table 107. India Paclitaxel Injection Sales Market Share by Application (2016-2021)
Table 108. India Paclitaxel Injection Sales by Application (2022-2027) & (K Units)
Table 109. India Paclitaxel Injection Sales Market Share by Application (2022-2027)
Table 110. Bristol-Myers Squibb Corporation Information
Table 111. Bristol-Myers Squibb Description and Business Overview
Table 112. Bristol-Myers Squibb Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Bristol-Myers Squibb Paclitaxel Injection Product
Table 114. Bristol-Myers Squibb Recent Development
Table 115. Celgene Corporation Corporation Information
Table 116. Celgene Corporation Description and Business Overview
Table 117. Celgene Corporation Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Celgene Corporation Paclitaxel Injection Product
Table 119. Celgene Corporation Recent Development
Table 120. Hospira Corporation Information
Table 121. Hospira Description and Business Overview
Table 122. Hospira Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Hospira Paclitaxel Injection Product
Table 124. Hospira Recent Development
Table 125. Biological E. Corporation Information
Table 126. Biological E. Description and Business Overview
Table 127. Biological E. Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Biological E. Paclitaxel Injection Product
Table 129. Biological E. Recent Development
Table 130. Taj Accura Corporation Information
Table 131. Taj Accura Description and Business Overview
Table 132. Taj Accura Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Taj Accura Paclitaxel Injection Product
Table 134. Taj Accura Recent Development
Table 135. Khandelwal Laboratories Corporation Information
Table 136. Khandelwal Laboratories Description and Business Overview
Table 137. Khandelwal Laboratories Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Khandelwal Laboratories Paclitaxel Injection Product
Table 139. Khandelwal Laboratories Recent Development
Table 140. Luye Pharma Corporation Information
Table 141. Luye Pharma Description and Business Overview
Table 142. Luye Pharma Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Luye Pharma Paclitaxel Injection Product
Table 144. Luye Pharma Recent Development
Table 145. Beijing Youcare Corporation Information
Table 146. Beijing Youcare Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Beijing Youcare Description and Business Overview
Table 148. Beijing Youcare Paclitaxel Injection Product
Table 149. Beijing Youcare Recent Development
Table 150. Beijing Union Corporation Information
Table 151. Beijing Union Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Beijing Union Description and Business Overview
Table 153. Beijing Union Paclitaxel Injection Product
Table 154. Beijing Union Recent Development
Table 155. Haiyao Corporation Information
Table 156. Haiyao Description and Business Overview
Table 157. Haiyao Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Haiyao Paclitaxel Injection Product
Table 159. Haiyao Recent Development
Table 160. Chuntch Corporation Information
Table 161. Chuntch Description and Business Overview
Table 162. Chuntch Paclitaxel Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Chuntch Paclitaxel Injection Product
Table 164. Chuntch Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Paclitaxel Injection Distributors List
Table 168. Paclitaxel Injection Customers List
Table 169. Paclitaxel Injection Market Trends
Table 170. Paclitaxel Injection Market Drivers
Table 171. Paclitaxel Injection Market Challenges
Table 172. Paclitaxel Injection Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Paclitaxel Injection Product Picture
Figure 2. Global Paclitaxel Injection Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Paclitaxel Injection Sales Market Share by Application in 2021 & 2027
Figure 6. Ovarian Cancer Examples
Figure 7. Breast Cancer Examples
Figure 8. Cervical Cancer Examples
Figure 9. Pancreatic Cancer Examples
Figure 10. Other Examples
Figure 11. Global Paclitaxel Injection Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Paclitaxel Injection Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Paclitaxel Injection Sales (K Units) Growth Rate (2016-2027)
Figure 14. Global Paclitaxel Injection Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 15. Global Paclitaxel Injection Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Paclitaxel Injection Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Paclitaxel Injection Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Paclitaxel Injection Sales (K Units) Growth Rate (2016-2027)
Figure 19. Europe Paclitaxel Injection Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Paclitaxel Injection Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Paclitaxel Injection Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Paclitaxel Injection Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Paclitaxel Injection Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Paclitaxel Injection Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Paclitaxel Injection Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Paclitaxel Injection Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Paclitaxel Injection Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Paclitaxel Injection Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Paclitaxel Injection Players Market Share by Revenue in Paclitaxel Injection: 2016 & 2020
Figure 30. Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Paclitaxel Injection Revenue Share by Type (2016-2021)
Figure 32. Global Paclitaxel Injection Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Paclitaxel Injection Revenue Share by Application (2016-2021)
Figure 34. Global Paclitaxel Injection Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Paclitaxel Injection Sales Market Share by Type in 2020
Figure 36. North America Paclitaxel Injection Sales Market Share by Application in 2020
Figure 37. Europe Paclitaxel Injection Sales Market Share by Type in 2020
Figure 38. Europe Paclitaxel Injection Sales Market Share by Application in 2020
Figure 39. China Paclitaxel Injection Sales Market Share by Type in 2020
Figure 40. China Paclitaxel Injection Sales Market Share by Application in 2020
Figure 41. Japan Paclitaxel Injection Sales Market Share by Type in 2020
Figure 42. Japan Paclitaxel Injection Sales Market Share by Application in 2020
Figure 43. Southeast Asia Paclitaxel Injection Sales Market Share by Type in 2020
Figure 44. Southeast Asia Paclitaxel Injection Sales Market Share by Application in 2020
Figure 45. India Paclitaxel Injection Sales Market Share by Type in 2020
Figure 46. India Paclitaxel Injection Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Paclitaxel Injection
Figure 49. Manufacturing Process Analysis of Paclitaxel Injection
Figure 50. Paclitaxel Injection Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
パクリタキセルのグローバル市場2021 Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol". In the l…- 注射用ミカファンギンナトリウムのグローバル市場2021 Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered …
- オンコロジー注射薬のグローバル市場調査 2019年 The global Oncology Injection Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Oncology Injection Drug volume and value at global level, regional level and company level. From a global perspecti…
- 世界のマイクロニードル＆ニードルフリー噴射システム市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Microneedles and Needle-Free Injection Systems Market The global Microneedles and Needle-Free Injection Systems market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accura…
- 電動式射出成形機のグローバル市場2021 Unlike traditional hydraulic injection molding machines, which use energy even while idle, all-electric injection molding machines consume energy only when required for a given action, and motor output is matched to load requirements. Market Analysis and Insights: Global Electric Injection Moulding …